{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:00:42Z","timestamp":1791669642047,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009655","name":"Sunovion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jaac.2017.10.006","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T04:46:15Z","timestamp":1507956375000},"page":"1015-1025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study"],"prefix":"10.1016","volume":"56","author":[{"given":"Melissa P.","family":"DelBello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Cucchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Loebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2017.10.006_bib1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4088\/JCP.10m06290","article-title":"Meta-analysis of epidemiologic studies of pediatric bipolar disorder","volume":"72","author":"Van Meter","year":"2011","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/070674370705200703","article-title":"Adult bipolar disorder is continuous with pediatric bipolar disorder","volume":"52","author":"Chang","year":"2007","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1034\/j.1399-5618.2001.30405.x","article-title":"Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder","volume":"3","author":"Findling","year":"2001","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2017.10.006_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.biopsych.2005.04.004","article-title":"Bipolar diagnoses in community mental health: Achenbach Child Behavior Checklist profiles and patterns of comorbidity","volume":"58","author":"Youngstrom","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.63.10.1139","article-title":"Phenomenology of children and adolescents with bipolar spectrum disorders","volume":"63","author":"Axelson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib7","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1542\/peds.2008-0841","article-title":"Quality of life in pediatric bipolar disorder","volume":"123","author":"Freeman","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2017.10.006_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jad.2008.07.001","article-title":"Psychosocial functioning among bipolar youth","volume":"114","author":"Goldstein","year":"2009","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaac.2017.10.006_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1468-2850.2011.01266.x","article-title":"Interpersonal functioning in pediatric bipolar disorder","volume":"18","author":"Keenan-Miller","year":"2011","journal-title":"Clin Psychol Sci Pract"},{"key":"10.1016\/j.jaac.2017.10.006_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1399-5618.2005.00263.x","article-title":"History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk","volume":"7","author":"Goldstein","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2017.10.006_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1399-5618.2010.00886.x","article-title":"Suicidality in pediatric bipolar disorder: predictor or outcome of family processes and mixed mood presentation?","volume":"13","author":"Algorta","year":"2011","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2017.10.006_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jad.2009.12.029","article-title":"Clinical and psychosocial correlates of non-suicidal self-injury within a sample of children and adolescents with bipolar disorder","volume":"125","author":"Esposito-Smythers","year":"2010","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaac.2017.10.006_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/appi.ajp.2009.08101569","article-title":"Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study","volume":"166","author":"Birmaher","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1542\/peds.2015-0743","article-title":"Lithium in the acute treatment of bipolar I disorder: a placebo-controlled study","volume":"136","author":"Findling","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2017.10.006_bib15","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1176\/appi.ajp.2007.06111932","article-title":"Olanzapine versus placebo in the treatment of adolescents with bipolar mania","volume":"164","author":"Tohen","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1399-5618.2009.00750.x","article-title":"Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study","volume":"11","author":"Haas","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2017.10.006_bib17","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.4088\/JCP.11m07424","article-title":"Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial","volume":"74","author":"Pathak","year":"2013","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib18","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaac.2015.09.007","article-title":"Asenapine for the acute treatment of pediatric manic or mixed episodes of bipolar I disorder","volume":"54","author":"Findling","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.chi.0000194567.63289.97","article-title":"A\u00a0double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania","volume":"45","author":"DelBello","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/cap.2013.0105","article-title":"Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial","volume":"24","author":"Findling","year":"2014","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2017.10.006_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-5618.2009.00728.x","article-title":"A\u00a0double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder","volume":"11","author":"DelBello","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2017.10.006_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaac.2014.12.012","article-title":"Olanzapine\/fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial","volume":"54","author":"Detke","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib23","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2017.10.006_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chc.2005.08.007","article-title":"Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents","volume":"15","author":"Correll","year":"2006","journal-title":"Child Adolesc Psychiatr Clin North Am"},{"key":"10.1016\/j.jaac.2017.10.006_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":"Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jaac.2017.10.006_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-009-1626-0","article-title":"The 5-HT7 receptor and disorders of the nervous system: an overview","volume":"206","author":"Hedlund","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jaac.2017.10.006_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuropharm.2013.01.023","article-title":"Effects of lurasidone in behavioral models of depression: role of the 5-HT7 receptor subtype","volume":"70","author":"Cates","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jaac.2017.10.006_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","article-title":"Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.2013.13070985","article-title":"Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2015.15060770","article-title":"Lurasidone for the treatment of major depressive disorder with mixed features: a randomized, double-blind, placebo-controlled study","volume":"173","author":"Suppes","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib31","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jaac.2017.10.006_bib32","series-title":"Children\u2019s Depression Rating Scale\u2013Revised: Manual","author":"Poznanski","year":"1996"},{"key":"10.1016\/j.jaac.2017.10.006_bib33","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children\u2013Present and Lifetime Version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A\u00a0rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaac.2017.10.006_bib36","series-title":"ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare publication (ADM) 76-338","author":"Guy","year":"1976"},{"key":"10.1016\/j.jaac.2017.10.006_bib37","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00004583-200209000-00006","article-title":"The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties","volume":"41","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archpsyc.1987.01800210069011","article-title":"Further measures of the psychometric properties of the Children\u2019s Global Assessment Scale","volume":"44","author":"Bird","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.chi.0000198590.38325.81","article-title":"Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q): reliability and validity","volume":"45","author":"Endicott","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/108705470100500204","article-title":"Validation of the ADHD Rating Scale as a clinician administered and scored instrument","volume":"5","author":"Faries","year":"2001","journal-title":"J\u00a0Atten Disord"},{"key":"10.1016\/j.jaac.2017.10.006_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mpr.7","article-title":"ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument","volume":"14","author":"Zhang","year":"2005","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.jaac.2017.10.006_bib42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/arclin\/acp010","article-title":"Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex","volume":"24","author":"Maruff","year":"2009","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.jaac.2017.10.006_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00004583-200503000-00006","article-title":"Treatment guidelines for children and adolescents with bipolar disorder","volume":"44","author":"Kowatch","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2017.10.006_bib45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.290.8.1033","article-title":"Sertraline pediatric depression study group. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials","volume":"290","author":"Wagner","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2017.10.006_bib46","doi-asserted-by":"crossref","unstructured":"Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry. 2006;45:280-288.","DOI":"10.1097\/01.chi.0000192250.38400.9e"},{"key":"10.1016\/j.jaac.2017.10.006_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1742-1241.2010.02587.x","article-title":"Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic","volume":"65","author":"Citrome","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaac.2017.10.006_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S1092852915000917","article-title":"Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study","volume":"21","author":"Correll","year":"2016","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jaac.2017.10.006_bib49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1017\/S109285291300093X","article-title":"Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study","volume":"19","author":"Citrome","year":"2014","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jaac.2017.10.006_bib50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/da.22479","article-title":"Lurasidone in the long-term treatment of patients with bipolar disorder: a 24-week open-label extension study","volume":"33","author":"Ketter","year":"2016","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jaac.2017.10.006_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40345-017-0075-7","article-title":"Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment","volume":"5","author":"Pikalov","year":"2017","journal-title":"Int J Bipolar Disord"},{"key":"10.1016\/j.jaac.2017.10.006_bib52","doi-asserted-by":"crossref","unstructured":"Goldman R, Loebel A, Cucchiaro J, Deng L, Findling RL. Efficacy and safety of lurasidone in adolescents with schizophrenia: a 6-week, randomized, placebo-controlled study J Child Adolesc Psychopharmacol. 2017;27:516-525.","DOI":"10.1089\/cap.2016.0189"},{"key":"10.1016\/j.jaac.2017.10.006_bib53","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.CIR.0000060923.07573.F2","article-title":"Obesity, insulin resistance, diabetes, and cardiovascular risk in children","volume":"107","author":"Steinberger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jaac.2017.10.006_bib54","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIR.0000000000000229","article-title":"Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association","volume":"132","author":"Goldstein","year":"2015","journal-title":"Circulation"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856717317720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856717317720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:23:57Z","timestamp":1760192637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856717317720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0890856717317720"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2017.10.006","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}